Evaluation of the Clinical Course of Methicillin-resistant Staphylococcus Aureus Infections in Consideration of the Efficacy of Linezolid

Linezolid is used as a first-line treatment for methicillin-resistant Staphylococcus aureus (MRSA) infections. We aimed to analyze the clinical courses of patients who received linezolid therapy in order to determine the most appropriate point for assessing the validity of linezolid therapy and identify predictors of the clinical outcomes of linezolid therapy for early stage MRSA infections.